Leman Damla Kotan

Leman Damla Kotan

Auto-generated profile, based on publicly available information

Leman Damla Kotan

Çukurova University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ATAli Kemal Topaloglu
Ali Kemal Topaloglu
FRFrank Reimann
Frank Reimann
MGMetin Guclu
Metin Guclu
AYAyse Serap Yalin
Ayse Serap Yalin
LKL Damla Kotan
L Damla Kotan
RSRobert K Semple
Robert K Semple

16 February 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
ATAli Kemal Topaloglu
Ali Kemal Topaloglu
JTJavier A. Tello
Javier A. Tello
LKL. Damla Kotan
L. Damla Kotan
MOMehmet N. Ozbek
Mehmet N. Ozbek
MYM. Bertan Yilmaz
M. Bertan Yilmaz
BYBilgin Yuksel
Bilgin Yuksel
Gonadotropin-releasing hormone (GnRH) is the central regulator of gonadotropins, which stimulate gonadal function. Hypothalamic neurons that produce kisspeptin and neurokinin B stimulate GnRH release. Inactivating mutations in the genes encoding the human kisspeptin receptor (KISS1R, formerly called GPR54), neurokinin B (TAC3), and the neurokinin B receptor (TACR3) result in pubertal failure. However, human kisspeptin loss-of-function mutations have not been described, and contradictory findings have been reported in Kiss1-knockout mice. We describe an inactivating mutation in KISS1 in a large consanguineous family that results in failure of pubertal progression, indicating that functional kisspeptin is important for puberty and reproduction in humans. (Funded by the Scientific and Technological Research Council of Turkey [TÜBİTAK] and others.)

1 December 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MWMichelle A. Wood-Trageser
Michelle A. Wood-Trageser
FGFatih Gürbüz
Fatih Gürbüz
SYSvetlana A. Yatsenko
Svetlana A. Yatsenko
EJElizabeth P. Jeffries
Elizabeth P. Jeffries
LKL. Damla Kotan
L. Damla Kotan
ARAleksandar Rajkovic
Aleksandar Rajkovic

1 December 2010 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YLYun Li
Yun Li
KLKathrin Laue
Kathrin Laue
STSamia Temtamy
Samia Temtamy
MAMona Aglan
Mona Aglan
LKL. Damla Kotan
L. Damla Kotan
BWBernd Wollnik
Bernd Wollnik

1 October 2009 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
TGTulay Guran
Tulay Guran
GTGwen Tolhurst
Gwen Tolhurst
ABAbdullah Bereket
Abdullah Bereket
NRNuno Rocha
Nuno Rocha
KPKeith Porter
Keith Porter
ATAli Kemal Topaloglu
Ali Kemal Topaloglu
Context: The neurokinin B (NKB) receptor, encoded by TACR3, is widely expressed within the central nervous system, including hypothalamic nuclei involved in regulating GnRH release. We have recently reported two mutations in transmembrane segments of the receptor and a missense mutation in NKB in patients with normosmic isolated hypogonadotropic hypogonadism (nIHH). Patients and Methods: We sequenced the TACR3 gene in a family in which three siblings had nIHH. The novel mutant receptor thus identified was studied in a heterologous expression system using calcium flux as the functional readout. Results: All affected siblings were homozygous for the His148Leu mutation, in the first extracellular loop of the NKB receptor. The His148Leu mutant receptor exhibited profoundly impaired signaling in response to NKB (EC50 = 3 ± 0.1 nm and >;5 μm for wild-type and His148Leu, respectively). The location of the mutation in an extracellular part of the receptor led us also to test whether senktide, a synthetic NKB analog, may retain ability to stimulate the mutant receptor. However, the signaling activity of the His148Leu receptor in response to senktide was also severely impaired (EC50 = 1 ± 1 nm for wild-type and no significant response of His148Leu to 10 μm). Conclusions: Homozygosity for the TACR3 His148Leu mutation leads to failure of sexual maturation in humans, whereas signaling by the mutant receptor in vitro in response to either NKB or senktide is severely impaired. These observations further strengthen the link between NKB, the NKB receptor, and regulation of human reproductive function. Hypogonadism due to a novel TACR3 mutation.

1 October 2014 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
ATAli Kemal Topaloglu
Ali Kemal Topaloglu
ALAlejandro Lomniczi
Alejandro Lomniczi
DKDoris Kretzschmar
Doris Kretzschmar
GDGregory A. Dissen
Gregory A. Dissen
LKL. Damla Kotan
L. Damla Kotan
SOSergio R. Ojeda
Sergio R. Ojeda
Gordon Holmes syndrome (GHS) is characterized by cerebellar ataxia/atrophy and normosmic hypogonadotropic hypogonadism (nHH). The underlying pathophysiology of this combined neurodegeneration and nHH remains unknown. We aimed to provide insight into the disease mechanism in GHS. We studied a cohort of 6 multiplex families with GHS through autozygosity mapping and whole-exome sequencing. We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine. Wild-type PNPLA6, but not PNPLA6 bearing these mutations, rescued a well-established Drosophila neurodegenerative phenotype caused by the absence of sws, the fly ortholog of mammalian PNPLA6. Inhibition of NTE activity in the LβT2 gonadotrope cell line diminished LH response to GnRH by reducing GnRH-stimulated LH exocytosis, without affecting GnRH receptor signaling or LHβ synthesis. These results suggest that NTE-dependent alteration of phospholipid homeostasis in GHS causes both neurodegeneration and impaired LH release from pituitary gonadotropes, leading to nHH.